HIGHLIGHTS
- who: Zi-Hang Chen from the Department of Radiation Oncology, Yat-sen University Cancer Road East, Guangzhou, Peopleu2019s Republic of China have published the article: Thyroid dysfunction in Chinese nasopharyngeal carcinoma after anti-PD-1 therapy and its association with treatment response, in the Journal: BMC Medicine of December/31,/2021
- what: Considering the increasing use of anti-PD-1 immunotherapy in nonmetastatic NPC patients, this study aims to illustrate the incidence and clinical course of immune-related thyroid dysfunction and its role as a predictor of survival in nonmetastatic NPC. The study reported a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.